Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.
暂无分享,去创建一个
Jose Perez-Calatayud | Facundo Ballester | Mark J Rivard | Geoffrey S Ibbott | Ali S Meigooni | Jeffrey F Williamson | Ron S Sloboda | Zoubir Ouhib | F. Ballester | J. Williamson | G. Ibbott | L. Dewerd | R. Sloboda | M. Rivard | A. Meigooni | R. Das | J. Pérez-Calatayud | Rupak K Das | Z. Ouhib | Larry A Dewerd
[1] R. M. Sievert. Die γ-Strahlungsintensitat an der Ober-Flache und in der Nachsten Umgebung von Radiumnadeln , 1930 .
[2] 이윤석. Report of the AAPM Radiation Therapy Committee의 Task Group No.66에 의한 전산화 단층촬영 모의치료기의 정도 관리 , 2005 .
[3] G. Daskalov. Erratum: “Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source” [Med. Phys. 25, 2200–2208 (1998)] , 2000 .
[4] Jose Perez-Calatayud,et al. Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air. , 2010, Medical physics.
[5] R. Nath,et al. Influence of the variation of energy spectra with depth in the dosimetry of 192Ir using LiF TLD. , 1988, Physics in medicine and biology.
[6] J. Dempsey,et al. Validation of a precision radiochromic film dosimetry system for quantitative two-dimensional imaging of acute exposure dose distributions. , 2000, Medical physics.
[7] J. Williamson,et al. Template-guided interstitial implants: Cs-137 reusable sources as a substitute for Ir-192. , 1987, Radiology.
[8] Assessment of the relative dose distribution around an 192Ir line source using a liquid ionization chamber. , 1999, Medical physics.
[9] L A DeWerd,et al. LiF:Mg,Ti TLD response as a function of photon energy for moderately filtered x-ray spectra in the range of 20-250 kVp relative to 60Co. , 2008, Medical physics.
[10] Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source. , 2002, Medical physics.
[11] E. Kouwenhoven,et al. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source. , 2000, Medical physics.
[12] Barry N. Taylor,et al. Guidelines for Evaluating and Expressing the Uncertainty of NIST Measurement Results 1994 Edition , 1994 .
[13] Lizhong Liu,et al. Determination of 137Cs dosimetry parameters according to the AAPM TG-43 formalism. , 2004, Medical physics.
[14] Ravinder Nath,et al. Erratum: “Supplement to the 2004 update of the AAPM Task Group No. 43 Report” [Med. Phys. 34, 2187–2205 (2007)] , 2010 .
[15] O. Chibani,et al. Monte Carlo dose calculations in homogeneous media and at interfaces: a comparison between GEPTS, EGSnrc, MCNP, and measurements. , 2002, Medical physics.
[16] A. Meigooni,et al. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source. , 2002, Medical physics.
[17] Mark J Rivard,et al. Anniversary paper: past and current issues, and trends in brachytherapy physics. , 2008, Medical physics.
[18] Kirsten Boedeker,et al. An analysis of MCNP cross-sections and tally methods for low-energy photon emitters. , 2002, Physics in medicine and biology.
[19] Frank-André Siebert,et al. Quality assurance of brachytherapy afterloaders using a multi-slit phantom. , 2007, Physics in medicine and biology.
[20] Feyzi Inanc,et al. Integral-transport-based deterministic brachytherapy dose calculations. , 2003, Physics in medicine and biology.
[21] C. Haie-meder,et al. Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience. , 2002, International journal of radiation oncology, biology, physics.
[22] Jose Perez-Calatayud,et al. TG-43 U1 based dosimetric characterization of model 67-6520 Cs-137 brachytherapy source. , 2009, Medical physics.
[23] Influence of phantom material and dimensions on experimental 192Ir dosimetry. , 2009 .
[24] F Ballester,et al. Technical note: Monte Carlo derivation of TG-43 dosimetric parameters for radiation therapy resources and 3M Cs-137 sources. , 2005, Medical physics.
[25] J. J. Fan,et al. Report on the dosimetry of a new design 125Iodine brachytherapy source. , 1999, Medical physics.
[26] J. Williamson,et al. Analytical approach to heterogeneity correction factor calculation for brachytherapy. , 1998, Medical physics.
[27] Dimos Baltas,et al. The physics of modern brachytherapy for onocology , 2006 .
[28] F Ballester,et al. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds. , 2004, Medical physics.
[29] Prospects for quantitative two-dimensional radiochromic film dosimetry for low dose-rate brachytherapy sources. , 2006, Medical physics.
[30] M. Rivard,et al. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. , 2010, Medical physics.
[31] A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities. , 2006, Medical physics.
[32] A convolution algorithm for brachytherapy dose computations in heterogeneous geometries. , 1991, Medical physics.
[33] J F Williamson,et al. Dependence of radiochromic film optical density post-exposure kinetics on dose and dose fractionation. , 2003, Medical physics.
[34] J. Williamson. Monte Carlo and analytic calculation of absorbed dose near 137Cs intracavitary sources. , 1988, International journal of radiation oncology, biology, physics.
[35] Anders Ahnesjö,et al. Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation. , 2003, Medical physics.
[36] G. Starkschall,et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. , 1998, Medical physics.
[37] Dragan Tubic,et al. Idealized line source configuration for permanent 125I prostate implants. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] F Ballester,et al. Monte Carlo dosimetry of the Buchler high dose rate 192Ir source , 2001, Physics in medicine and biology.
[39] J. W. Winston,et al. Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. , 2008, Medical physics.
[40] J. Palta,et al. Comprehensive QA for Radiation Oncology , 1994 .
[41] S. H. Cho,et al. Anisotropy measurements of a high dose rate Ir-192 source in air and in polystyrene. , 1994, Medical physics.
[42] J. Williamson,et al. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source. , 1994, International Journal of Radiation Oncology, Biology, Physics.
[43] H. Meertens,et al. Screens in ovoids of a Selectron cervix applicator. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] J J Jezioranski,et al. The effect of seed orientation deviations on the quality of 125I prostate implants. , 2001, Physics in medicine and biology.
[45] K. Breitman. Dose-rate tables for clinical 137Cs sources sheathed in platinum. , 1974, The British journal of radiology.
[46] E. Poon,et al. Comparison of dose calculation algorithms for colorectal cancer brachytherapy treatment with a shielded applicator. , 2008, Medical physics.
[47] L. Sakelliou,et al. Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source. , 1998, Medical physics.
[48] Lellery Storm,et al. Photon cross sections from 1 keV to 100 MeV for elements Z=1 to Z=100 , 1970 .
[49] J F Williamson,et al. Dependence of radiochromic film response kinetics on fractionated doses. , 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[50] S. Chiu‐Tsao,et al. Dose response characteristics of new models of GAFCHROMIC films: dependence on densitometer light source and radiation energy. , 2004, Medical physics.
[51] R. Capote,et al. Radial dose functions for 103Pd, 125I, 169Yb and 192Ir brachytherapy sources: an EGS4 Monte Carlo study. , 2000, Physics in medicine and biology.
[52] Jeffrey F Williamson,et al. Brachytherapy technology and physics practice since 1950: a half-century of progress , 2006, Physics in medicine and biology.
[53] Luc Beaulieu,et al. Modeling a hypothetical 170Tm source for brachytherapy applications. , 2011, Medical physics.
[54] F. Ballester,et al. Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from emitted electrons. , 2009, Medical physics.
[55] W. Butler,et al. Supplement to the 2004 update of the AAPM Task Group No. 43 Report. , 2007, Medical physics.
[56] R. Yaes. Late normal tissue injury from permanent interstitial implants. , 2001, International journal of radiation oncology, biology, physics.
[57] D. Granero,et al. Revision of the dosimetric parameters of the CSM11 LDR Cs-137 source , 2011, Journal of contemporary brachytherapy.
[58] Equivalent phantom sizes and shapes for brachytherapy dosimetric studies of 192Ir and 137Cs. , 2008, Medical physics.
[59] W. Lutz,et al. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities. , 1993, Medical physics.
[60] Mark J Rivard,et al. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources. , 2006, Medical physics.
[61] P. Kohr,et al. Calculation of dose decrease in a finite phantom of a Ir192 point source. , 2007, Medical physics.
[62] L. Anderson,et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .
[63] R Nath,et al. On the depth of penetration of photons and electrons for intravascular brachytherapy. , 1999, Cardiovascular radiation medicine.
[64] S. Chiu‐Tsao,et al. Treatment planning dosimetric parameters for 192Ir seed at short distances: effects of air channels and neighboring seeds based on Monte Carlo study. , 2004, Medical physics.
[65] F. Ballester,et al. A monte carlo study of dose rate distribution around the specially asymmetric CSM3-a 137Cs source. , 2001, Physics in medicine and biology.
[66] F Ballester,et al. Dosimetry characteristics of the Plus and 12i Gammamed PDR 192Ir sources. , 2001, Medical physics.
[67] D. Schaart,et al. On the applicability of the AAPM TG-60/TG-43 dose calculation formalism to intravascular line sources: proposal for an adapted formalism. , 2001, Medical physics.
[68] L. Sakelliou,et al. Dose rate calculations around 192Ir brachytherapy sources using a Sievert integration model. , 2000, Physics in medicine and biology.
[69] J. Battista,et al. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd. , 2001, Medical physics.
[70] I. Kawrakow. On the effective point of measurement in megavoltage photon beams. , 2006, Medical physics.
[71] S. Klevenhagen. An experimental study of the dose distribution in water around 137Cs tubes used in brachytherapy. , 1973, The British journal of radiology.
[72] D Granero,et al. Phantom size in brachytherapy source dosimetric studies. , 2004, Medical physics.
[73] B L Diffey,et al. An experimental and calculated dose distribution in water around CDC K-type caesium-137 sources. , 1975, Physics in medicine and biology.
[74] J F Williamson,et al. Dosimetric modeling of the microselectron high-dose rate 192Ir source by the multigroup discrete ordinates method. , 2000, Medical physics.
[75] J F Williamson,et al. TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy. , 1995, Physics in medicine and biology.
[76] P Baras,et al. A Monte Carlo investigation of the dosimetric characteristics of the VariSource 192Ir high dose rate brachytherapy source. , 1999, Medical physics.
[77] L. Sakelliou,et al. Dose rate distributions around 60Co, 137Cs, 198Au, 192Ir, 241Am, 125I (models 6702 and 6711) brachytherapy sources and the nuclide 99Tcm. , 1992, Physics in medicine and biology.
[78] J. H. Hubbell,et al. Tables of X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients 1 keV to 20 MeV for Elements Z = 1 to 92 and 48 Additional Substances of Dosimetric Interest , 1995 .
[79] R. Sloboda,et al. EGS4 dosimetry calculations for cylindrically symmetric brachytherapy sources. , 1996, Medical physics.
[80] R. Nath,et al. Photon energy dependence of the sensitivity of radiochromic film and comparison with silver halide film and LiF TLDs used for brachytherapy dosimetry. , 1991, Medical physics.
[81] A dosimetric comparison of Yb169 and Ir192 for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities. , 2006, Medical physics.
[82] M. Gillin,et al. Energy dependence and dose response of Gafchromic EBT2 film over a wide range of photon, electron, and proton beam energies. , 2010, Medical physics.
[83] Influence of phantom material and dimensions on experimental Ir-192 dosimetry , 2009 .
[84] D. W. O. Rogersb,et al. EGSnrc Monte Carlo calculated dosimetry parameters for 192 Ir and 169 Yb brachytherapy sources , 2008 .
[85] X. Li,et al. Evaluation of EGS4/PRESTA multiple-scattering algorithms for 90Sr/90Y intravascular brachytherapy dosimetry. , 2000, Physics in medicine and biology.
[86] W. Dries,et al. Measurement and calculation of the dose at large distances from brachytherapy sources: Cs-137, Ir-192, and Co-60. , 1996, Medical physics.
[87] L. Kochian. Author to whom correspondence should be addressed , 2006 .
[88] J F Williamson,et al. Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate 192Ir sources. , 1995, Medical physics.
[89] Firas Mourtada,et al. Comparison of a finite-element multigroup discrete-ordinates code with Monte Carlo for radiotherapy calculations , 2006, Physics in medicine and biology.
[90] Omar Chibani,et al. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. , 2005, Medical physics.
[91] K Doi,et al. Physical characteristics of scattered radiation in diagnostic radiology: Monte Carlo simulation studies. , 1985, Medical physics.
[92] Barry N. Taylor,et al. Guidelines for Evaluating and Expressing the Uncertainty of Nist Measurement Results , 2017 .
[93] P. Higgins,et al. Radial dose distribution of 192Ir and 137Cs seed sources. , 1989, Medical physics.
[94] F. Ballester,et al. Fitted dosimetric parameters of high dose-rate 192Ir sources according to the AAPM TG43 formalism. , 2001, Medical physics.
[95] A. Meigooni,et al. Evaluation of TG-43 recommended 2D-anisotropy function for elongated brachytherapy sources. , 2006, Medical physics.
[96] H. Bartelink,et al. Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. , 2004, Journal of the National Cancer Institute.
[97] J. Williamson,et al. Monte Carlo modeling of the transverse-axis dose distribution of the model 200 103Pd interstitial brachytherapy source. , 2000, Medical physics.
[98] R. Nath,et al. On the choice of phantom material for the dosimetry of 192Ir sources. , 1988, International journal of radiation oncology, biology, physics.
[99] F. Ballester,et al. Study of encapsulated 170Tm sources for their potential use in brachytherapy. , 2010, Medical physics.
[100] B. Clark,et al. Experimental determination of dosimetry functions of Ir-192 sources. , 1998, Medical physics.
[101] D. Rogersb,et al. More accurate fitting of 125 I and 103 Pd radial dose functions , 2008 .
[102] F. Ballester,et al. Monte Carlo calculation of dose rate distributions around the Walstam CDC.K-type 137Cs sources. , 2001, Physics in medicine and biology.
[103] J. Palta,et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. , 1994, Medical physics.
[104] J. Schwade,et al. Scattering effects on the dosimetry of iridium-192. , 1991, Medical physics.
[105] A. Meigooni,et al. Dosimetric evaluation of GAFCHROMIC® XR type T and XR type R films , 2005, Journal of applied clinical medical physics.
[106] David C Medich,et al. Monte Carlo characterization of an ytterbium-169 high dose rate brachytherapy source with analysis of statistical uncertainty. , 2005, Medical physics.
[107] L. Sakelliou,et al. Monte Carlo dosimetry of 60Co HDR brachytherapy sources. , 2003, Medical physics.
[108] Anders Ahnesjö,et al. Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation. , 2005, Medical physics.
[109] J. Williamson. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources. , 1996, International journal of radiation oncology, biology, physics.
[110] D. Pearson,et al. Measurements and Monte Carlo calculations to determine the absolute detector response of radiochromic film for brachytherapy dosimetry. , 2001, Medical physics.
[111] A. Meigooni,et al. Dosimetric characterization of Ir-192 LDR elongated sources. , 2008, Medical physics.
[112] G. Glasgow,et al. Specific gamma-ray constant and exposure rate constant of 192Ir. , 1979, Medical physics.
[113] K. Zourari,et al. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries. , 2010, Medical physics.
[114] R. Capote,et al. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study. , 1998, Physics in medicine and biology.
[115] R Wang,et al. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy. , 2000, Medical physics.
[116] G. Hartmann,et al. Monte Carlo calculation of energy build-up factors in the range from 15 keV to 100 keV, with special reference to the dosimetry of 125I seeds , 1988 .
[117] Dimos Baltas,et al. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study. , 2005, International journal of radiation oncology, biology, physics.
[118] A. Meigooni,et al. Treatment‐planning considerations for prostate implants with the new linear RadioCoil™ Pd103 brachytherapy source , 2005, Journal of applied clinical medical physics.
[119] G Zarris,et al. Accurate Monte Carlo calculations of the combined attenuation and build-up factors, for energies (20-1500 keV) and distances (0-10 cm) relevant in brachytherapy. , 1991, Physics in medicine and biology.
[120] D Baltas,et al. Beta versus gamma dosimetry close to Ir-192 brachytherapy sources. , 2001, Medical physics.
[121] F. Ballester,et al. Dosimetric characteristics of the CDC-type miniature cylindrical 137Cs brachytherapy sources. , 2002, Medical physics.
[122] S. Awan. Erratum: “Cylindrical coordinate‐based TG‐43U1 parameters for dose calculation around elongated brachytherapy sources” , 2008, Journal of applied clinical medical physics.
[123] R. W. Roussin,et al. Description of the DLC-99/HUGO package of photon interaction data in ENDF/B-V format , 1983 .
[124] E. Poon,et al. Development of a scatter correction technique and its application to HDR 192Ir multicatheter breast brachytherapy. , 2009, Medical physics.
[125] A. Pradhan,et al. In-phantom response of LiF TLD-100 for dosimetry of 192Ir HDR source. , 2000, Medical physics.
[126] D. Baltas,et al. An analytical dosimetry model as a step towards accounting for inhomogeneities and bounded geometries in 192Ir brachytherapy treatment planning. , 2003, Physics in medicine and biology.
[127] Omar Chibani,et al. Dosimetric effects of seed anisotropy and interseed attenuation for Pd103 and I125 prostate implants. , 2005, Medical physics.
[128] J. Williamson,et al. High dose-rate brachytherapy treatment delivery: report of the AAPM Radiation Therapy Committee Task Group No. 59. , 1998, Medical physics.
[129] J. Williamson,et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2003, Medical physics.
[130] R. Sloboda,et al. Influence of source geometry and materials on the transverse axis dosimetry of 192Ir brachytherapy sources. , 1998, Physics in medicine and biology.
[131] J. Williamson,et al. Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. , 1998, Medical physics.
[132] R. Taylor,et al. More accurate fitting of 125I and 103Pd radial dose functions. , 2008, Medical physics.
[133] F Ballester,et al. Monte Carlo study of the dose rate distributions for the Ir2.A85-2 and Ir2.A85-1 Ir-192 afterloading sources. , 2008, Medical physics.
[134] P Baras,et al. Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source. , 2000, Medical physics.
[135] J. Williamson,et al. One-dimensional scatter-subtraction method for brachytherapy dose calculation near bounded heterogeneities. , 1993, Medical physics.
[136] F. Ballester,et al. Monte Carlo calculation of dose rate distributions around 0.5 and 0.6 mm in diameter 192Ir wires , 1999 .
[137] Omar Chibani,et al. MCPI©: A sub-minute Monte Carlo dose calculation engine for prostate implants. , 2005, Medical physics.
[138] W. J. Meredith,et al. The attenuation and scattering in a phantom of gamma rays from some radionuclides used in mould and interstitial gamma-ray therapy. , 1966, The British journal of radiology.
[139] L. Sakelliou,et al. Limitations of the point and line source approximations for the determination of geometry factors around brachytherapy sources. , 2000, Medical physics.
[140] V. S. Shirley. Nuclear data sheets for A = 192 , 1983 .
[141] W. De Neve,et al. On the determination of the effective transmission factor for stainless steel ovoid shielding segments and estimation of their shielding efficacy for the clinical situation. , 1994, Medical physics.
[142] R. Taylor,et al. EGSnrc Monte Carlo calculated dosimetry parameters for Ir192 and Yb169 brachytherapy sources. , 2008, Medical physics.
[143] F Ballester,et al. Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: evaluation of applicator attenuation and superposition approximation effects. , 2004, Medical physics.
[144] Facundo Ballester,et al. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[145] M. Lindstrom,et al. Effect of source encapsulation on the energy spectra of 192Ir and 137Cs seed sources. , 1991, Physics in medicine and biology.
[146] F. Ballester,et al. Technical note: Monte-Carlo dosimetry of the HDR 12i and Plus 192Ir sources. , 2001, Medical physics.
[147] David A Jaffray,et al. Energy dependence (75 kVp to 18 MV) of radiochromic films assessed using a real-time optical dosimeter. , 2007, Medical physics.
[148] M. Rivard. Refinements to the geometry factor used in the AAPM Task Group Report No. 43 necessary for brachytherapy dosimetry calculations. American Association of Physicists in Medicine. , 1999, Medical physics.
[149] Jose Perez-Calatayud,et al. Monte Carlo calculation of dose rate distributions around Ir192 wires , 1997 .
[150] M. Kuettel,et al. Quantifying IOHDR brachytherapy underdosage resulting from an incomplete scatter environment. , 2005, International journal of radiation oncology, biology, physics.
[151] F. Ballester,et al. Equivalent phantom sizes and shapes for brachytherapy dosimetric studies of Ir192 and Cs137. , 2008, Medical physics.
[152] D Granero,et al. A dosimetric study on the Ir-192 high dose rate flexisource. , 2006, Medical physics.
[153] R Nath,et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine. , 1999, Medical physics.
[154] S. Chiu‐Tsao,et al. The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source. , 2001, International journal of radiation oncology, biology, physics.
[155] F. Ballester,et al. Assessment of the linear reference air kerma rate of 192Ir wires , 2001, Physics in medicine and biology.
[156] Anders Ahnesjö,et al. Optimization of the computational efficiency of a 3D, collapsed cone dose calculation algorithm for brachytherapy. , 2008, Medical physics.
[157] Martin J Butson,et al. Weak energy dependence of EBT gafchromic film dose response in the 50 kVp-10 MVp X-ray range. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[158] S. Chiu‐Tsao,et al. High-sensitivity GafChromic film dosimetry for 125I seed. , 1994, Medical physics.
[159] D Baltas,et al. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source. , 2003, Medical physics.
[160] E. Poon,et al. Development of a scatter correction technique and its application to HDR I192r multicatheter breast brachytherapy. , 2009, Medical physics.
[161] Luc Beaulieu,et al. The evolution of brachytherapy treatment planning. , 2009, Medical physics.
[162] R. Taylor,et al. Benchmarking brachydose: Voxel based EGSnrc Monte Carlo calculations of TG-43 dosimetry parameters. , 2007, Medical physics.
[163] Jan Seuntjens,et al. Absorption spectra time evolution of EBT-2 model GAFCHROMIC film. , 2010, Medical physics.
[164] F. Ballester,et al. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type 137Cs source. , 2000, Medical physics.
[165] R Nath,et al. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Recommendations of the American Association of Physicists in Medicine Radiation Therapy Committee. Ad Hoc Subcommittee of the Radiation Therapy Committee. , 1998, Medical physics.
[166] D. Rogers,et al. Monte Carlo calculated absorbed-dose energy dependence of EBT and EBT2 film. , 2010, Medical physics.
[167] D Baltas,et al. Dosimetry comparison of 192Ir sources. , 2002, Medical physics.
[168] D. Baltas,et al. Dosimetry of 192Ir wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism. , 2001, Medical physics.
[169] J F Williamson,et al. Monte Carlo evaluation of kerma at a point for photon transport problems. , 1987, Medical physics.
[170] F Ballester,et al. Monte Carlo and experimental derivation of TG43 dosimetric parameters for CSM-type Cs-137 sources. , 2004, Medical physics.
[171] F. Ballester,et al. A Monte Carlo investigation of the dosimetric characteristics of the CSM11 137Cs source from CIS. , 2000, Medical physics.
[172] K. Shortt,et al. The response of lif thermoluminescence dosemeters to photon beams in the energy range from 30 kV x rays to 60Co gamma rays. , 2003, Radiation protection dosimetry.
[173] R. Capote,et al. Anisotropy functions for low energy interstitial brachytherapy sources: an EGS4 Monte Carlo study , 2001, Physics in medicine and biology.
[174] M. Lindstrom,et al. The dose distribution surrounding 192Ir and 137Cs seed sources. , 1991, Physics in medicine and biology.
[175] F Ballester,et al. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source , 2005, Physics in medicine and biology.
[176] F Ballester,et al. Technical note: Dosimetric study of a new Co-60 source used in brachytherapy. , 2007, Medical physics.
[177] Z. Chen,et al. Dose rate constant and energy spectrum of interstitial brachytherapy sources. , 2001, Medical physics.
[178] E. Podgoršak,et al. Rotational total skin electron irradiation with a linear accelerator , 2008, Journal of applied clinical medical physics.
[179] J. Seuntjens,et al. Evaluation of EBT-2 model GAFCHROMIC film performance in water. , 2010, Medical physics.
[180] Technical note: EGSnrc-based dosimetric study of the BEBIG 60Co HDR brachytherapy sources. , 2010, Medical physics.
[181] José Pérez-Calatayud,et al. Dosimetric prerequisites for routine clinical use of photon emitting brachytherapy sources with average energy higher than 50 kev. , 2007, Medical physics.
[182] G. Gustafson,et al. A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. , 1999, International journal of radiation oncology, biology, physics.
[183] Larry A DeWerd,et al. Determination of exit skin dose for I192r intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. , 2010, Medical physics.
[184] L. L. Meisberger,et al. The effective attenuation in water of the gamma rays of gold 198, iridium 192, cesium 137, radium 226, and cobalt 60. , 1968, Radiology.
[185] K. Harrington,et al. Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[186] Javier Vijande,et al. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2. , 2011, Medical physics.
[187] F. Ballester,et al. Monte Carlo calculation of dose rate distributions around 192Ir wires. , 1997, Medical physics.
[188] Frank Verhaegen,et al. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy. , 2009, Medical physics.
[189] R. Pötter,et al. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[190] Firas Mourtada,et al. Validation of a new grid-based Boltzmann equation solver for dose calculation in radiotherapy with photon beams , 2010, Physics in medicine and biology.
[191] Ravinder Nath,et al. Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: Recommendations of the AAPM Therapy Physics Committee Task Group No. 149. , 2007, Medical physics.
[192] S. Chiu‐Tsao,et al. Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies. , 2005, Medical physics.
[193] Larry A DeWerd,et al. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. , 2011, Medical physics.
[194] J F Williamson,et al. Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds. , 1991, Medical physics.
[195] Mark J. Rivard,et al. Dosimetry revisited for the HDR {sup 192}Ir brachytherapy source model mHDR-v2 , 2010 .
[196] J. Williamson,et al. Monte Carlo-based dose-rate tables for the Amersham CDCS.J and 3M model 6500 137Cs tubes. , 1998, International journal of radiation oncology, biology, physics.
[197] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[198] Brachytherapy scatter dose calculation in heterogeneous media: I. A microbeam ray-tracing method for the single-scatter contribution. , 2007, Physics in medicine and biology.
[199] D. Medich,et al. Dependence of Yb-169 absorbed dose energy correction factors on self-attenuation in source material and photon buildup in water. , 2010, Medical physics.
[200] X. Li,et al. Dose characterization in the near-source region for two high dose rate brachytherapy sources. , 2002, Medical Physics (Lancaster).
[201] J F Williamson,et al. Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. , 1997, Medical physics.
[202] Ravinder Nath,et al. Dose calculation formalisms and consensus dosimetry parameters for intravascular brachytherapy dosimetry: recommendations of the AAPM Therapy Physics Committee Task Group No. 149. , 2007, Medical physics.
[203] R. Sloboda,et al. Brachytherapy scatter dose calculation in heterogeneous media: II. Empirical formulation for the multiple-scatter contribution , 2007, Physics in medicine and biology.
[204] F. Ballester,et al. Evaluation of interpolation methods for TG-43 dosimetric parameters based on comparison with Monte Carlo data for high-energy brachytherapy sources , 2010, Journal of contemporary brachytherapy.